Stocks and Investing Stocks and Investing
Thu, April 25, 2024

Sarah James Reiterated (AMED) at Hold and Held Target at $101 on, Apr 25th, 2024


Published on 2024-10-28 10:38:37 - WOPRAI, Sarah James
  Print publication without navigation


Sarah James of Cantor Fitzgerald, Reiterated "Amedisys, Inc." (AMED) at Hold and Held Target at $101 on, Apr 25th, 2024.

Sarah has made no other calls on AMED in the last 4 months.



There are 2 other peers that have a rating on AMED. Out of the 2 peers that are also analyzing AMED, 1 agrees with Sarah's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • John Ransom of "Raymond James" Maintained at Hold on, Tuesday, March 26th, 2024


This is the rating of the analyst that currently disagrees with Sarah


  • Ben Hendrix of "RBC Capital" Maintained at Buy with Increased Target to $100 on, Monday, March 25th, 2024
Contributing Sources